首页 | 本学科首页   官方微博 | 高级检索  
   检索      

肿瘤抑素抗肿瘤相关肽对肝癌细胞增殖和凋亡的影响
引用本文:王淑静,刘兴汉,季宇彬,陈 宁.肿瘤抑素抗肿瘤相关肽对肝癌细胞增殖和凋亡的影响[J].生物工程学报,2008,24(1):68-73.
作者姓名:王淑静  刘兴汉  季宇彬  陈 宁
作者单位:1. 哈尔滨商业大学药物研究所,哈尔滨,150076;东北农业大学兽医学博士后流动站,哈尔滨,150030;哈尔滨商业大学药学院,哈尔滨,150076
2. 黑龙江省生物医药工程重点实验室一省部共建国家重点实验室培育基地,哈尔滨,150081
3. 哈尔滨商业大学药物研究所,哈尔滨,150076
4. 哈尔滨商业大学药学院,哈尔滨,150076
基金项目:国家自然基金资助项目(No.30472035), 黑龙江省自然科学基金资助项目(No.TD2005-21), 黑龙江省教育厅自然基金资助项目(No. 11511104)。
摘    要:肿瘤抑素抗肿瘤相关肽-19肽是由肿瘤抑素185~203位氨基酸组成, 具有直接抑制黑色素瘤细胞生长作用, 但其对肝癌细胞增殖和凋亡是否有影响, 对肝癌是否具有治疗作用还需进一步研究。本研究中采用基因工程技术将合成19肽基因与载体pTYB2重组后进行蛋白表达、纯化获得19肽。通过MTT法、生长曲线观察19肽对人肝癌细胞生长抑制作用; TUNEL标记法、流式细胞仪细胞周期检测法、透射电镜观察19肽对肝癌细胞凋亡的影响; 小鼠H22腹水型转移型肝癌实体瘤抑瘤实验证明其体内的抑瘤作用。MTT实验和生长曲线实验表明随着19肽浓度的增加肝癌细胞的存活率下降。在相同19肽浓度下, 随着作用时间延长存活细胞逐渐减少。电镜观察治疗组细胞出现明显凋亡, 流式细胞仪可检测到前G1峰, TUNEL标记法也证实治疗组可见明显的凋亡细胞, 体内19肽作用的小鼠H22腹水型转移型肝癌的抑瘤率达48.46%。可见, 肿瘤抑素19肽可抑制肝癌细胞生长, 促进肝癌细胞凋亡, 对肝癌具有一定的治疗作用。

关 键 词:肿瘤抑素    细胞增殖    细胞凋亡    肿瘤治疗
收稿时间:2007-03-26
修稿时间:2007-09-17

Effect of Tumstatin Anti-tumor Peptide on Proliferation and Apoptosis of Hepatocarcinoma Cell
Shujing Wang,Xinghan Liu,Yubin Ji and Ning Chen.Effect of Tumstatin Anti-tumor Peptide on Proliferation and Apoptosis of Hepatocarcinoma Cell[J].Chinese Journal of Biotechnology,2008,24(1):68-73.
Authors:Shujing Wang  Xinghan Liu  Yubin Ji and Ning Chen
Abstract:In this study, the basic sequences of 19peptide were synthesized and inserted into vector pTYB2. After being expressed and purified, the soluble 19peptide was obtained. The inhibiting effect on hepatocarcinoma cell was selected by 3-4, 5-dimehyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay and cell growth curve. The apoptosis index was observed using TdT-mediated dUTP nick end labeling (TUNEL), flow cytometry and transmission electron microscope (TEM). Its anti-tumor activity in vivo was verified in H22 ascitic fluid transfevent hepatocarcinoma of mice. 3-4, 5-dimehyl-2-thiazolyl]-2, 5-di- phenyl-2H-tetrazolium bromide (MTT) assay and cell growth curve showed cell viability decrease with the 19peptide.Survival hepatocarcinoma cell decreased with time. In the treatment group, obvious change of apoptosis, the appearance of sub-G1 phase and dyed brown cells were seen by transmission electron microscope (TEM), flow cytometry and TdT-mediated dUTP nick end labeling (TUNEL), The inhibition rate of mouse H22 ascitic fluid transfevent hepatocarcinoma growth was 48.46%. As a whole, 19peptide could directly inhibit hepatocarcinoma cell proliferation and promote hepatocarcinoma cell apoptosis.
Keywords:Tumstatin  cell proliferation  cell apoptosis  tumor therapy
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号